Similarly, fenofibrate and the combination (but not simvastatin) significantly increased the percentage of buoyant LDL cholesterol constituting total LDL cholesterol.
Objective To investigate the effects of micronized fenofibrate on low density lipoprotein (LDL) subfraction profiles in type IV hyperlipidemic subjects.
We separated the subfractions of LDL by precipitating method and density gradient ultracentrifugation, and identified the subfraction by electronphoresis and electron microscope.